These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26537684)

  • 1. Structural Studies of Chikungunya Virus-Like Particles Complexed with Human Antibodies: Neutralization and Cell-to-Cell Transmission.
    Porta J; Mangala Prasad V; Wang CI; Akahata W; Ng LF; Rossmann MG
    J Virol; 2016 Feb; 90(3):1169-77. PubMed ID: 26537684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralization.
    Sun S; Xiang Y; Akahata W; Holdaway H; Pal P; Zhang X; Diamond MS; Nabel GJ; Rossmann MG
    Elife; 2013 Apr; 2():e00435. PubMed ID: 23577234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity.
    Long F; Fong RH; Austin SK; Chen Z; Klose T; Fokine A; Liu Y; Porta J; Sapparapu G; Akahata W; Doranz BJ; Crowe JE; Diamond MS; Rossmann MG
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13898-903. PubMed ID: 26504196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies.
    Porta J; Jose J; Roehrig JT; Blair CD; Kuhn RJ; Rossmann MG
    J Virol; 2014 Sep; 88(17):9616-23. PubMed ID: 24920796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency.
    Warter L; Lee CY; Thiagarajan R; Grandadam M; Lebecque S; Lin RT; Bertin-Maghit S; Ng LF; Abastado JP; Desprès P; Wang CI; Nardin A
    J Immunol; 2011 Mar; 186(5):3258-64. PubMed ID: 21278338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.
    Fox JM; Long F; Edeling MA; Lin H; van Duijl-Richter MKS; Fong RH; Kahle KM; Smit JM; Jin J; Simmons G; Doranz BJ; Crowe JE; Fremont DH; Rossmann MG; Diamond MS
    Cell; 2015 Nov; 163(5):1095-1107. PubMed ID: 26553503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of Chikungunya virus inhibition by monoclonal antibodies.
    Zhou QF; Fox JM; Earnest JT; Ng TS; Kim AS; Fibriansah G; Kostyuchenko VA; Shi J; Shu B; Diamond MS; Lok SM
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27637-27645. PubMed ID: 33087569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.
    Williams JA; Gui L; Hom N; Mileant A; Lee KK
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
    Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
    MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative Chikungunya Virus Membrane Fusion and Its Substoichiometric Inhibition by CHK-152 Antibody.
    Blijleven JS; Bouma EM; van Duijl-Richter MKS; Smit JM; van Oijen AM
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
    Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chikungunya fever vaccine utilizing an insect-specific virus platform.
    Erasmus JH; Auguste AJ; Kaelber JT; Luo H; Rossi SL; Fenton K; Leal G; Kim DY; Chiu W; Wang T; Frolov I; Nasar F; Weaver SC
    Nat Med; 2017 Feb; 23(2):192-199. PubMed ID: 27991917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of human monoclonal antibodies to treat Chikungunya virus infection.
    Fric J; Bertin-Maghit S; Wang CI; Nardin A; Warter L
    J Infect Dis; 2013 Jan; 207(2):319-22. PubMed ID: 23125446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing Antibodies Inhibit Chikungunya Virus Budding at the Plasma Membrane.
    Jin J; Galaz-Montoya JG; Sherman MB; Sun SY; Goldsmith CS; O'Toole ET; Ackerman L; Carlson LA; Weaver SC; Chiu W; Simmons G
    Cell Host Microbe; 2018 Sep; 24(3):417-428.e5. PubMed ID: 30146390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits.
    Metz SW; Martina BE; van den Doel P; Geertsema C; Osterhaus AD; Vlak JM; Pijlman GP
    Vaccine; 2013 Dec; 31(51):6092-6. PubMed ID: 24099875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.
    Chua CL; Sam IC; Merits A; Chan YF
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004960. PubMed ID: 27571254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.
    Weber C; Büchner SM; Schnierle BS
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003684. PubMed ID: 25905779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Neutralization Assay Using an eGFP Chikungunya Virus.
    Deng CL; Liu SQ; Zhou DG; Xu LL; Li XD; Zhang PT; Li PH; Ye HQ; Wei HP; Yuan ZM; Qin CF; Zhang B
    Viruses; 2016 Jun; 8(7):. PubMed ID: 27367716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody.
    Kaufmann B; Nybakken GE; Chipman PR; Zhang W; Diamond MS; Fremont DH; Kuhn RJ; Rossmann MG
    Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12400-4. PubMed ID: 16895988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.